Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer

British Journal of Cancer

Volumn 92, Issue 5, 2005, Pages 913-920

  Schaefer, C ^a,b   Kim, G G ^a   Albers, A ^a   Hoermann, K ^b   Myers, E N ^c   Whiteside, T L ^a,c  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

CD4+ T cell subsets; Head and neck cancer CD4+CD25+ T cells; Regulatory T cells (T reg)

Indexed keywords

CD27 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR7; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; LIPOCORTIN 5;

ADULT; AGED; ALCOHOL CONSUMPTION; APOPTOSIS; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HYPOPHARYNX CANCER; LARYNX CANCER; MALE; MOUTH CANCER; PHARYNX CANCER; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CARCINOMA, SQUAMOUS CELL; FEMALE; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN-2; REFERENCE VALUES; T-LYMPHOCYTES;

EID: 16244409219     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602407     Document Type: Article

References (31)

1. Akbar AN, Borthwick NI, Wickremasinghe RG, Panayoitidis P, Pilling D, Bofill M, Krajewski S, Reed JC, Salmon M (1996) Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol 26: 294-299
2. Albers AE, Kim GG, Ferris RL, DeLeo AB, Whiteside TL (2004) Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory CD4+CD25+ cells at tumor sites. Cancer Immunol Immunother (in press)
3. dim natural killer cell subset in patients with cancer. Eur J Immunol 33: 119-124
4. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, von Boehmer H, Buer J, Hansen W (2004) Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 34: 623-630
5. Campbell JJ, Murphy KE, Kunkel EJ, Brightling CE, Soler D, Shen Z, Boisvert J, Greenberg HB, Vierra MA, Goodman SB, Genovese MC, Wardlaw AJ, Butcher EC, Wu L (2001) CCR7 expression and memory T cell diversity in humans. J Immunol 166: 877-884
6. Cosmi L, Liotta F, Lazzeri E, Francalanci M, Angeli R, Mazzinghi B, Santarlasci V, Manetti R, Vanini V, Romagnani P, Maggi E, Romagnani S, Annunziato F (2003) Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 102: 4107-4114
7. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G (2001) Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood. J Exp Med 193: 1303-1310
8. Hoffmann TK, Dworacki G, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL (2002) Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 8: 2553-2562
9. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH (2001) Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J Exp Med 193: 1285-1294
10. - T cells have signaling defects in patients with head and neck cancer. Br J Cancer 88: 223-230
11. Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL (2004a) Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res 10: 3755-3762
12. Kuss I, Saito T, Johnson JT, Whiteside TL (1999) Clinical significance of decreased ζ chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin Cancer Res 5: 329-334
13. Kuss I, Schaefer C, Godfrey TE, Ferris RL, Harris JM, Gooding W, Whiteside TL (2004b) Recent thymic emigrants and subsets of naïve and memory T cells in the circulation of patients with head and neck cancer. Clin Immunol (in press)
14. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169: 2756-2761
15. Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD, Lechler RI (2001) Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells. Blood 98: 2736-2744
16. Ramsdell F (2003) Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 19: 165-168
17. Reichert TE, Rabinowich H, Johnson JT, Whiteside TL (1998) Human immune cells in the tumor microenvironment: mechanisms responsible for signaling and functional defects. J Immunother 21: 295-306
18. Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL (2002) Signaling abnormalities and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Clin Cancer Res 8: 3137-3145
19. Ronchetti S, Zollo O, Bruscoll S, Agostini M, Bianchini R, Nocentini G, Ayroldi E, Riccardi C (2004) GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol 34: 613-622
20. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Normura T, Toda M, Takahashi T (2001) Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182: 18-32
21. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712
22. Salmon M, Pilling D, Borthwick NJ, Viner N, Janossy G, Bacon PA, Akbar AN (1994) The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol 24: 892-899
23. Shevach EM (2000) Regulatory T cells in autoimmunity. Annu Rev Immunol 18: 423-449
24. Shevach EM (2004) Fatal attraction: tumors becon regulatory T cells. Nat Med 10: 900-901
25. Shimizu J, Yamazaki S, Sakaguchi S (1999) Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 163: 5211-5218
26. Sutmuller RP, van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP, Toes RE, Offringa R, Melief CJ (2001) Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocytes responses. J Exp Med 194: 823-832
27. Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN (2001) Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 31: 1122-1131
28. Whiteside TL (2004) Down-regulation of ζ chain expression in T cells: a biomarker of prognosis in cancer? Cancer Immunol Immunother 53: 865-876
29. Wolf AM, Wolf D, Steurer M, Gasti G, Gunsilius E, Grubeck-loebenstein B (2003) Increase in regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 9: 606-612
30. Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH (2001) Regulatory CD4+CD25+ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 61: 4766-4772
31. Woo EY, Yeh, H Chu CS, Schlienger K, Carroll RG, Riley JL, Kaiser LR, June CH (2002) Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 168: 4272-4276